MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) saw a recent divestiture of shares by one of its directors, which has drawn attention amid other significant corporate developments. On May 13, 2026, Charles Bland, who serves as a director at MACOM, executed a sale involving 800 shares of the company's common stock. This transaction amounted to $304,000, with each share being purchased at a price point of $380.00.
This direct selling activity occurred while MTSI stock was trading near its 52-week high of $401.25. The stock has demonstrated substantial upward momentum over the past year, recording an impressive surge of 213%. Currently, the company's market capitalization is valued at $28.81 billion, though investors should note that the shares are trading with a Price-to-Earnings (P/E) ratio of 162.79.
Analysis provided by InvestingPro indicates that, relative to its Fair Value, the stock appears overvalued, placing it among companies identified on the Most Overvalued list.
Following this disclosed transaction, Mr. Bland's remaining holdings in MACOM Technology Solutions Holdings, Inc. common stock total 14,338 shares. This information was officially recorded and disclosed via a Form 4 filing with the U.S. Securities and Exchange Commission.
The director's sale is situated against a backdrop of generally positive operational news for MACOM Technology Solutions. The company recently released its financial results for the second fiscal quarter of 2026, achieving figures that surpassed both earnings and revenue projections. Specifically, MTSI reported an adjusted earnings per share (EPS) of $1.09, which was higher than the anticipated figure of $1.07. Furthermore, revenue reached $289 million, exceeding the projected level of $285.18 million.
These strong results have attracted considerable attention from both industry analysts and potential investors. Building on this momentum, Needham upgraded its price target for MACOM shares significantly, raising it from $250 to $400 while maintaining a Buy rating. The firm cited two primary factors supporting the upgrade: the company's reported earnings beat and the substantial increase contained within its fiscal third-quarter 2026 guidance.
Further bolstering confidence in the corporation's financial health, MACOM’s book-to-bill ratio for the second quarter of 2026 climbed to 1.5:1. This metric represents a historical peak for the company, underscoring its robust market position and positive industry sentiment.
Risks
- The stock is currently trading near its 52-week high and carries a P/E ratio of 162.79, leading some analyses to suggest it may be overvalued relative to its Fair Value.
- A director's recent sale of shares suggests potential profit-taking or rebalancing by internal stakeholders.
More from Insider Trading
Risks
- The stock is currently trading near its 52-week high and carries a P/E ratio of 162.79, leading some analyses to suggest it may be overvalued relative to its Fair Value.
- A director's recent sale of shares suggests potential profit-taking or rebalancing by internal stakeholders.